The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Integrative genomic profiling of RCC treated with second-line nivolumab.
 
Pankaj Vats
No Relationships to Disclose
 
Saravana Dhanasekaran
No Relationships to Disclose
 
Rohit Malik
No Relationships to Disclose
 
Yupin Zhang
No Relationships to Disclose
 
Xuhong Cao
No Relationships to Disclose
 
Fengyun Su
No Relationships to Disclose
 
Rui Wang
No Relationships to Disclose
 
Alicia Ali
No Relationships to Disclose
 
Stephanie Erickson
No Relationships to Disclose
 
Megan Dahl
No Relationships to Disclose
 
Charles Voliva
Employment - BMSi
Stock and Other Ownership Interests - BMSi
Travel, Accommodations, Expenses - BMSi
 
Rohit Mehra
No Relationships to Disclose
 
Arul Chinnaiyan
Stock and Other Ownership Interests - Esanik; Medsyn Biopharma; OncoFusion Therapeutics; Oncopia Therapeutics; Tempus
Consulting or Advisory Role - Tempus
Patents, Royalties, Other Intellectual Property - University of Michigan royalties.
 
Ajjai Shivaram Alva
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck; Pfizer
Speakers' Bureau - AstraZeneca
Research Funding - Arcus Biosciences (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Progenics (Inst); Prometheus (Inst); Roche (Inst)